Ausgabe Sonderheft 2/2004
Current and new antitumor necrosis factor agents in perspective
Inhalt (8 Artikel)
Does safety make a difference in selecting the right TNF antagonist?
Roy Fleischmann, David Yocum
Does route of administration affect the outcome of TNF antagonist therapy?
Sergio Schwartzman, G James Morgan Jr
Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?
Sergio Schwartzman, Roy Fleischmann, G James Morgan Jr
Treating psoriatic arthritis: how effective are TNF antagonists?
Alice B Gottlieb, Christian E Antoni